The results showed that FK506 treatment reduced cognitive impairments, lowered the levels of specific characteristics of postsynaptic deficits, including PSD-95 and NR2B, and reversed the long-term potentiation deficiency and dendritic spine impairments [47]. Here, DLG4 is linked to Cognitive impairment.